Skip to main content
Home
Loading...
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube

Menu top

  • Assistance

User account menu

  • Log in
Home

Main navigation

  • Home
  • Programme
Menu Login
Close

Main navigation mobile

  • Home
  • Programme

Menu top

  • Assistance
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
Filters
Filters Close
Poster topics
  • Aerobiology and pollution (41)
  • Allergen immunotherapy (81)
  • AllergoOncology (15)
  • Allergy asthma and a sport (4)
  • Allergy diagnosis (235)
  • Allied health and primary care (20)
  • Anaphylaxis (113)
  • Artificial Intelligence (12)
  • Asthma (185)
  • Basic immunology (58)
  • Biologicals (90)
  • Biomarkers (64)
  • Comparative veterinary allergology (1)
  • COVID19 (11)
  • Dermatology (125)
  • Drug allergy (172)
  • ENT (29)
  • Environmental allergy and climate change (31)
  • Eosinophilic esophagitis (21)
  • Epidemiology (66)
  • x Epithelial cell biology (8)
  • Food allergy (195)
  • Genomics and proteomics (17)
  • Immune deficiencies and autoimmunity (80)
  • Immunomodulation and nutrition (13)
  • Infections (27)
  • Insect venom hypersensitivities (19)
  • x Mastocytosis and mast cells (24)
  • Microbiome (9)
  • Occupational allergy (27)
  • Ocular allergy (5)
  • One Health (13)
  • Pediatrics (144)
  • Prevention (40)
  • Systems medicine (13)
Poster available until
  • Until platform closure (1)
Poster categories
  • e-Thematic Poster Session (1)
  • Thematic Poster Session (30)
keywords
Session Reference
  • L-TPS11 (1)
  • L-TPS13 (1)
  • L-TPS18 (1)
  • TPS11 (1)
  • TPS13 (1)
  • TPS15 (2)
  • TPS16 (1)
  • TPS31 (1)
  • TPS37 (3)
  • TPS38 (2)
  • TPS44 (1)
  • TPS56 (1)
  • TPS57 (1)
  • TPS68 (1)
  • TPS71 (11)
  • TPS73 (2)
32 results
Thumbnail

D2.127 - The bacterial lysate OM-85 mitigates HDM-induced allergic inflammation through the airway epithelial cell- macrophage crosstalk

Thumbnail

D2.299 - A novel synthetic molecule LN49 suppressed oxidative stress and inflammation in skin epithelial and fibroblast cells via activating Nrf-2 signaling pathway

Thumbnail

D2.306 - Sodium dodecyl sulfate impairs the skin epithelial barrier by inducing oxidative stress in human skin

Thumbnail

D3.142 - Differential Impact of Heat-not-Burn Tobacco Products and Conventional Cigarettes on Pulmonary Cells and Immune Response

Thumbnail

D3.372 - SLC27A2 marks lipid peroxidation in nasal epithelial cells driven by type 2 inflammation in chronic rhinosinusitis with nasal polyps

Thumbnail

D3.432 - Anti-inflammatory properties of IPA on epithelial barrier sites

Thumbnail

D3.433 - Transcriptome kinetics of esophageal epithelial cells in response to interleukin 13

Thumbnail

D2.390 - Effects of Cigarette Smoke on Expression and Rhythmicity ofr Core Circadian Genes in Peripheral Blood Mononuclear Cells (PBMC) and Bronchial Epithelial Cells

Thumbnail

000766 - Clonal mast cell disorders, allergy to hymenoptera venom and venom immunotherapy – our experience

Thumbnail

D1.231 - When Antihistamines Paradoxically Worsen Chronic Spontaneous Urticaria: Trust Your Patient

Thumbnail

- D3.117 - Targeting Mast Cells with Briquilimab, an Anti-Human c-Kit (CD117) Antibody, Mitigates COPD-Like Features in an Allergen and Cigarette Smoke-Exacerbated Asthma Model Using Humanized h/mCD117 Mice

Thumbnail

D3.419 - Prevalence of physical urticaria hives in patients with systemic mastocytosis and their relation to disease course – preliminary data

Thumbnail

D3.204 - Elevated Tryptase Levels in a Severe Asthmatic Patient Undergoing SCIT for Birch: Implications for Monitoring and Personalized Treatment

Thumbnail

D3.411 - Targeting MRGPRX2 for the Treatment of Mast Cell-Driven Diseases

Thumbnail

D3.412 - MRGPRX2 Specific Activation Signature is Enriched in Atopic Dermatitis Lesions and Wheals from Chronic Spontaneous Urticaria Compared to Adjacent Healthy Skin

Thumbnail

D3.413 - Development of the Mastocytosis Symptom Severity Daily Diary (MS2D2) for Non-Advanced Systemic Mastocytosis (NonAdvSM) Patients and Establishing Content Validity

Thumbnail

D3.414 - The Phase 2/3 Study of Elenestinib, a Highly Potent and Selective Tyrosine Kinase Inhibitor, in Patients With Indolent Systemic Mastocytosis

Thumbnail

D3.415 - Clinical manifestations of Hereditary alpha-tryptasemia (HaT) in Patients with Mast Cell Activation Syndromes

Thumbnail

D3.416 - Hereditary Alpha-Tryptasemia: A Case Series

Thumbnail

D3.417 - "Comprehensive Allergological Evaluation and Management of Severe Anaphylaxis to Vespid Venoms: A Case Study"

Pagination

  • Current page 1
  • Page 2
  • Next page Next
  • Last page Last
Download the app
The congress at your fingertips

Available on

App Store Google Play
QR Code Download
Mobile App Schedule page
Mobile App Home page
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
© 2025 EAACI
Made with   by CYIM